The FDA has started a review of an extension to the labelling for AstraZeneca’s influenza vaccine FluMist Quadrivalent which would allow it to be administered by patients
Ipsen has said that it plans to file a new marketing application for its treatment for itch in Alagille syndrome (ALGS), Bylvay, after failing to persuade an EMA committee
Faced with escalating costs, the US Defense Health Agency (DHA) is seeking a digital solution to the problem of managing chronic health conditions – and has turned to tele
New data from NHS England has revealed that the waiting list for community health services has topped one million for the first time, with children and young people dispro
Gilead Sciences has said it will soon start a clinical trial in Europe of its twice-yearly HIV injection Sunlenca for pre-exposure prophylaxis (PrEP), a potential successo
A virtual reality-based task could help differentiate people with Alzheimer’s disease from the normal cognitive impairment that occurs with age, according to a pilot study